Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Yotaro Matsuoka"'
Autor:
Kazuyuki Hirooka, Eri Nitta, Yoshiaki Kiuchi, Masaki Tanito, Shunsuke Nakakura, Tetsuya Baba, Hideaki Okumichi, Aisyah Muhlisah, Ariyanie Nurtania, Hiromitsu Onoe, Yotaro Matsuoka
Publikováno v:
BMJ Open Ophthalmology, Vol 9, Iss 1 (2024)
Background To investigate if there are improvements in trabeculectomy outcomes supporting filtration bleb formation caused by Rho-associated protein kinase (ROCK) inhibitors.Methods This prospective, multicentre, randomised, open-label clinical study
Externí odkaz:
https://doaj.org/article/ec770b42a59d4e588c84029e3f7df335
Autor:
Yuji Takayanagi, Mikihiro Yamanaka, Jo Fujihara, Yotaro Matsuoka, Yuko Gohto, Akira Obana, Masaki Tanito
Publikováno v:
Antioxidants, Vol 9, Iss 11, p 1100 (2020)
Advanced glycation end products (AGEs) are thought to play important roles in the pathogenesis of diabetic microangiopathy, particularly in the progression of diabetic retinopathy (DR). We assessed the levels of skin autofluorescence (sAF) to assess
Externí odkaz:
https://doaj.org/article/2d4d3cef28d044b9ac807be95c726b11
Autor:
Tomoki Shirakami, Mikihiro Yamanaka, Jo Fujihara, Yotaro Matsuoka, Yuko Gohto, Akira Obana, Masaki Tanito
Publikováno v:
Antioxidants, Vol 9, Iss 8, p 755 (2020)
Advanced glycation end products (AGEs), which are the products of a non-enzymatic reaction between reducing sugars and other macromolecules, are critical in aging, as well as metabolic and degenerative diseases. To assess the involvement of AGEs in g
Externí odkaz:
https://doaj.org/article/d21e34ef0d934695a1e49347bbdbbf51
Publikováno v:
American Journal of Ophthalmology. 228:1-7
Purpose To report a cluster of cases of toxic anterior-segment syndrome (TASS) in eyes implanted with a specific foldable acrylic intraocular lens (IOL) model. Design Retrospective case series. Methods The medical records were reviewed for 7 eyes of
Publikováno v:
Journal of Glaucoma. 30:e327-e333
Ahmed glaucoma valve (AGV) implantation in eyes with damaged iris-lens diaphragms ("1-chamber" eyes) resulted in mean intraocular pressure (IOP) and antiglaucoma medications decreases of 66% and 59% (P0.0001 for both), respectively, at the mean 23-mo
Autor:
Yasurou Koyama, Sachiko Kaidzu, Yong-Chul Kim, Yotaro Matsuoka, Tomoe Ishihara, Akihiro Ohira, Masaki Tanito
Publikováno v:
Antioxidants, Vol 8, Iss 4, p 79 (2019)
We examined the cytoprotective effect of quercetin via activator protein (AP-1) and the heat shock protein 70 (Hsp70) pathway against light-induced retinal degeneration in rats. Quercetin was administered intraperitoneally to Sprague-Dawley rats for
Externí odkaz:
https://doaj.org/article/bbc1f97681e54a28b24b46aa73240639
Autor:
Masaki, Tanito, Yotaro, Matsuoka
Publikováno v:
Clinical Ophthalmology.
Masaki Tanito,1 Yotaro Matsuoka2 1Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Shimane, Japan; 2Division of Ophthalmology, Matsue Red Cross Hospital, Matsue, Shimane, JapanCorrespondence: Masaki Tanito, Department of Op
Autor:
Kaoru Manabe, Mihoko Mochiji, Etsuyo Miyamoto, Yasutaka Takagi, Masaki Tanito, Sachiko Kaidzu, Aika Tsutsui, Yotaro Matsuoka
Publikováno v:
Journal of Clinical Biochemistry and Nutrition
We tested oral French maritime pine bark (40 mg)/bilberry fruit extract (90 mg) supplements for intraocular pressure-lowering effects in Japanese subjects with primary open-angle glaucoma. Eighteen subjects (29 eyes) were recruited with intraocular p
Publikováno v:
Clinical ophthalmology (Auckland, N.Z.). 16
Current therapeutic approaches for glaucoma aim to reduce intraocular pressure (IOP), which is the only available and reliable strategy proven to control the risk of disease development and progression. Omidenepag isopropyl (OMDI) is a novel topical
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology. 258:1343-1345